Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 13:13:863027.
doi: 10.3389/fendo.2022.863027. eCollection 2022.

Periprostatic Adipose Tissue Microenvironment: Metabolic and Hormonal Pathways During Prostate Cancer Progression

Affiliations
Review

Periprostatic Adipose Tissue Microenvironment: Metabolic and Hormonal Pathways During Prostate Cancer Progression

Paula Alejandra Sacca et al. Front Endocrinol (Lausanne). .

Abstract

The periprostatic adipose tissue (PPAT) is a site of invasion of prostate cancer (PCa) and is part of the microenvironment. It was shown that PPAT secretes factors and fatty acids (FAs) that alter the microenvironment of the PCa. The PPAT secretome of patients with PCa-T3 stage (PPAT-T3) has a metabolic profile enriched in several pathways related to energy production, indicating a greater energy requirement by the tumor, when compared to that of patients in the PCa-T2 stage (PPAT-T2). PPAT-T3 also shows enrichment in pathways related to hormone response, polyamine synthesis, and control of protein synthesis, through amino acid, RNA, and nucleotide metabolism. PPAT-T2 and PPAT-BPH secretomes have less complex metabolic profile, both related with energy balance, while PPAT-BPH has hormone response through insulin pathway. Undoubtedly, a deeper characterization of the human PPAT will lead to a better understanding of the disease and possibly allow new stratification factors and the design of a specific therapy that targets crucial components of the tumor microenvironment as another way to treat or control the disease.

Keywords: adipose tissue; benign prostatic hyperplasia; metabolism; microenvironment; periprostatic adipose tissue; prostate cancer; proteomics; secretome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Finley DS, Calvert VS, Inokuchi J, Lau A, Narula N, Petricoin EF, et al. . Periprostatic Adipose Tissue as a Modulator of Prostate Cancer Aggressiveness. J Urol (2009) 182:1621–7. doi: 10.1016/j.juro.2009.06.015 - DOI - PubMed
    1. Ribeiro RJ, Monteiro CP, Cunha VF, Azevedo AS, Oliveira MJ, Monteiro R, et al. . Tumor Cell-Educated Periprostatic Adipose Tissue Acquires an Aggressive Cancer-Promoting Secretory Profile. Cell Physiol Biochem (2012) 2:233–40. doi: 10.1159/000337604 - DOI - PubMed
    1. Sacca PA, Creydt VP, Choi H, Mazza ON, Fletcher SJ, Vallone VB, et al. . Human Periprostatic Adipose Tissue: Its Influence on Prostate Cancer Cells. Cell Physiol Biochem (2012) 30:113–22. doi: 10.1159/000339051 - DOI - PubMed
    1. Sacca PA, Mazza ON, Scorticati C, Vitagliano G, Casas G, Calvo JC. Human Periprostatic Adipose Tissue: Secretome From Patients With Prostate Cancer or Benign Prostate Hyperplasia. Cancer Genomics Proteomics (2019) 16:29–58. doi: 10.21873/cgp.20110 - DOI - PMC - PubMed
    1. Nassar ZD, Aref AT, Miladinovic D, Mah CY, Raj GV, Hoy AJ, et al. . Peri-Prostatic Adipose Tissue: The Metabolic Microenvironment of Prostate Cancer. BJU Int (2018) 121:9–21. doi: 10.1111/bju.14173 - DOI - PubMed

Publication types